Delivery Order SPE2DB22D3301-SPE2DB25FY2EU

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,296.91, is for the supply of 100 capsules of Propranolol ER 60 mg, a cardiovascular medication. The contract is a firm fixed-price arrangement with a period of performance running through January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAU32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,745,406 units of the medication Propranolol ER 60 mg capsule in quantities of 500s. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $50,283.61 and a performance period ending on April 1, 2025. This award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,088.92 firm fixed-price delivery order is for the supply of 100 units of 60 mg Propranolol ER capsules, a cardiovascular medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,799.94 firm fixed-price delivery order is for the supply of 100 counts of Propranolol ER 60 mg capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive...
This federal contract award from the Defense Logistics Agency (DLA) is for the procurement of 4,567,796,398 units of Propranolol ER 60 mg capsules in 100 count bottles. The $1,059.26 Firm Fixed Price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 4, 2025 and is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,209.06 firm fixed-price delivery order is for the supply of 100 units of 120 mg Propranolol ER capsules. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,106.10 firm fixed-price delivery order is for the supply of 4,568,077,610 units of the prescription medication Propranolol ER 160 mg capsules. The award is not associated with a set-aside program and has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00...
This federal contract award, identified as SPE2DB20D3103|SPE2DB25FM7Z1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,337,145 units of the drug Propranolol ER 60 mg capsules, with a total ceiling value of $2,078.40. This is a Firm Fixed Price delivery order contract with a period of performance running through February 24, 2025. The award does not...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,385.60, is for the delivery of 4,567,913,619 units of the prescription medication Propranolol ER 60 mg capsules in 100-count bottles. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,889.82 firm fixed-price delivery order is for the supply of 100 capsules of Propranolol ER 80 mg, a cardiovascular medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2EU
    Delivery Order

This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY2EU, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,800.43 firm fixed-price delivery order is for the supply of 4,567,694,414 units of the pharmaceutical product Propranolol ER 60 mg capsules.

The award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This particular award was not designated with any set-aside requirements, indicating open competition.

Generated 6/24/25, 9:47 AM